Baenosin Capsule
Product Images NDC 72988-0011

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Baenosin (NDC 72988-0011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lydia Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label)

This is a drug information sheet that warns patients with certain health conditions against taking the medication. Patients with rare inherited problems of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should avoid the medicine. Moreover, pregnant women or those expected to be pregnant, children, and people who have had a rash or an allergic reaction to medication, should consult a doctor before taking the medicine. It contains active ingredients, storage information, expiration date, and some warnings about possible side effects.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.